MedPath

Effect of Citrullus colocynthis on neurological symptoms caused by cancer

Phase 3
Conditions
Chemotherapy-induced peripheral neuropathy.
Drug-induced polyneuropathy
Registration Number
IRCT20150825023753N5
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with cancer who have symptoms of peripheral neuropathy
The duration between the patient's visit for enrolling to the study and the last time receiving chemotherapy is at most two month
A neurologist will recognize that their neuropathy is due to chemotherapy
Age between 18-80 years old

Exclusion Criteria

Patients with diabetes mellitus
Patients with brain metastasis
Patients with carpal tunnel syndrome
Unwilling to participate in the study
Creating acute psychological symptoms such as depression (such as taking medication)
Deficiency or high levels of vitamin B6 (according to your doctor's interview and examination)
Any positive history of allergic reaction or complications due to uising Citrullus colocynthis
Patients with serious illness

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chemotherapy Induced Peripheral Neuropathy score. Timepoint: Before and after. Method of measurement: Using of Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT).;Symptoms and concerns associated specifically with chemotherapy-induced neuropathy score. Timepoint: Before and after. Method of measurement: Using Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath